|
DK1320531T3
(da)
|
2000-08-10 |
2011-01-03 |
Pfizer Italia Srl |
Bicyclo-pyrazoler, der er aktive som kinase inhibitorer, fremgangsmåde til fremstilling deraf og farmaceutiske sammensætninger, der indeholder disse
|
|
WO2006101434A1
(en)
|
2005-03-22 |
2006-09-28 |
Astrazeneca Ab |
NOVEL TETRAHYDRO-1H-PYRIDO [4,3-b] INDOLE DERIVATIVES AS CB1’ RECEPTOR LIGANDS
|
|
FR2884252B1
(fr)
|
2005-04-08 |
2007-05-18 |
Aventis Pharma Sa |
Nouveaux derives d'isoindoles, compositions les contenant, leur preparation et leurs utilisations pharmaceutiques notamment en tant qu'inhibiteurs d'activites de la proteine chaperone hsp90
|
|
AR058223A1
(es)
|
2005-11-25 |
2008-01-23 |
Palau Pharma Sa |
Un comuesto de derivados de pirazoloisoquinolina, un procedimiento para l a preparacion de dicho compuesto y una composicion farmaceutica que comprende dicho compuesto
|
|
EP2223925A1
(en)
|
2006-10-09 |
2010-09-01 |
Takeda Pharmaceutical Company Limited |
Kinase inhibitors
|
|
WO2010138659A1
(en)
|
2009-05-27 |
2010-12-02 |
Ptc Therapeutics, Inc. |
Methods for treating brain tumors
|
|
MX373926B
(es)
|
2009-05-27 |
2020-07-10 |
Ptc Therapeutics Inc |
Metodos para tratar cancer y estados no neoplasicos.
|
|
WO2010138695A1
(en)
|
2009-05-27 |
2010-12-02 |
Ptc Therapeutics, Inc. |
Methods for treating neurofibromatosis
|
|
RS56042B1
(sr)
|
2010-06-10 |
2017-09-29 |
Seragon Pharmaceuticals Inc |
Modulatori estrogenih receptora i njihove upotrebe
|
|
US8853423B2
(en)
|
2010-06-17 |
2014-10-07 |
Seragon Pharmaceuticals, Inc. |
Indane estrogen receptor modulators and uses thereof
|
|
WO2013090829A1
(en)
|
2011-12-14 |
2013-06-20 |
Aragon Pharmaceuticals, Inc. |
Estrogen receptor modulators and uses thereof
|
|
US10987334B2
(en)
*
|
2012-07-13 |
2021-04-27 |
University Of Tennessee Research Foundation |
Method of treating ER mutant expressing breast cancers with selective androgen receptor modulators (SARMs)
|
|
LT2872482T
(lt)
|
2012-07-13 |
2020-12-28 |
Oncternal Therapeutics, Inc. |
Krūties vėžių gydymo būdas selektyviu androgeno receptoriaus moduliatoriumi
|
|
UY35590A
(es)
|
2013-05-28 |
2014-11-28 |
Astrazeneca Ab |
Nuevos compuestos para el tratamiento del cáncer
|
|
EA031077B1
(ru)
|
2013-06-19 |
2018-11-30 |
Серагон Фармасьютикалз, Инк. |
Модулятор рецептора эстрогена и его применения
|
|
CA2915534A1
(en)
|
2013-06-19 |
2014-12-24 |
Seragon Pharmaceuticals, Inc. |
Azetidine estrogen receptor modulators and uses thereof
|
|
WO2015092634A1
(en)
|
2013-12-16 |
2015-06-25 |
Novartis Ag |
1,2,3,4-tetrahydroisoquinoline compounds and compositions as selective estrogen receptor antagonists and degraders
|
|
TWI874834B
(zh)
|
2014-12-18 |
2025-03-01 |
瑞士商赫孚孟拉羅股份公司 |
四氫-吡啶并[3,4-b]吲哚雌激素受體調節劑及其用途
|
|
US20160175284A1
(en)
|
2014-12-18 |
2016-06-23 |
Genentech, Inc. |
Estrogen receptor modulators and uses thereof
|
|
WO2016097071A1
(en)
|
2014-12-18 |
2016-06-23 |
F. Hoffmann-La Roche Ag |
Estrogen receptor modulators and uses thereof
|
|
WO2016174551A1
(en)
|
2015-04-27 |
2016-11-03 |
Pfizer Inc. |
Anti-estrogenic compounds
|
|
KR20250152679A
(ko)
|
2015-04-29 |
2025-10-23 |
래디어스 파마슈티컬스, 인코포레이티드 |
암을 치료하는 방법
|
|
US10053451B2
(en)
|
2015-05-26 |
2018-08-21 |
Genentech, Inc. |
Heterocyclic estrogen receptor modulators and uses thereof
|
|
US10087191B2
(en)
|
2015-06-16 |
2018-10-02 |
Jiangsu Hengrui Medicine Co., Ltd. |
Piperidine derivative and preparation method and pharmaceutical use thereof
|
|
CN106518768B
(zh)
|
2015-09-15 |
2021-07-02 |
江苏恒瑞医药股份有限公司 |
丙烯酸类衍生物、其制备方法及其在医药上的应用
|
|
KR20240142622A
(ko)
|
2015-10-01 |
2024-09-30 |
올레마 파마슈티컬스 인코포레이티드 |
테트라히드로-1H-피리도[3,4-b]인돌 항에스트로겐 약물
|
|
HK1258851A1
(zh)
|
2015-11-09 |
2019-11-22 |
豪夫迈‧罗氏有限公司 |
四氢萘雌激素受体调节剂及其用途
|
|
JP6592197B2
(ja)
|
2015-11-12 |
2019-10-16 |
浙江海正薬業股▲ふん▼有限公司Ｚｈｅｊｉａｎｇ Ｈｉｓｕｎ Ｐｈａｒｍａｃｅｕｔｉｃａｌ ＣＯ．，ＬＴＤ． |
アクリル酸誘導体、製造方法、および医薬としてのその使用
|
|
CA3006683A1
(en)
|
2015-12-22 |
2017-06-29 |
Jiangsu Hengrui Medicine Co., Ltd. |
Benzopiperidine derivative, preparation method thereof and medical use thereof
|
|
AU2017235450A1
(en)
|
2016-03-15 |
2018-08-16 |
Merrimack Pharmaceuticals, Inc. |
Methods for treating ER+, HER2-, HRG+ breast cancer using combination therapies comprising an anti-ErbB3 antibody
|
|
EP3440067B1
(en)
|
2016-04-08 |
2021-05-26 |
F. Hoffmann-La Roche AG |
Tetrahydroisoquinoline estrogen receptor modulators and uses thereof
|
|
WO2017182493A1
(en)
|
2016-04-20 |
2017-10-26 |
Astrazeneca Ab |
Indazole derivatives for use in down-regulation of the estrogen receptor for the treatment of cancer
|
|
US20190233442A1
(en)
|
2016-05-06 |
2019-08-01 |
Xavier University Of Louisiana |
Selective estrogen receptor down-regulators (serds)
|
|
WO2018001232A1
(zh)
|
2016-06-29 |
2018-01-04 |
浙江海正药业股份有限公司 |
丙烯酸类衍生物及其制备方法和其在医药上的用途
|
|
US10149839B2
(en)
|
2016-07-25 |
2018-12-11 |
Astrazeneca Ab |
Chemical compounds
|
|
CN107814798B
(zh)
|
2016-09-14 |
2020-11-03 |
四川科伦博泰生物医药股份有限公司 |
3-取代丙烯酸类化合物及其制备方法和用途
|
|
US20180072711A1
(en)
|
2016-09-15 |
2018-03-15 |
Arvinas, Inc. |
Indole derivatives as estrogen receptor degraders
|
|
BR102016024814A2
(pt)
|
2016-10-24 |
2018-05-08 |
Aché Laboratórios Farmacêuticos S.A. |
composto, processo de obtenção do composto, composição farmacêutica, uso do composto e método de tratamento de desordens psiquiátricas e/ou distúrbios do sono
|
|
EP3640251B1
(en)
|
2016-10-24 |
2021-12-08 |
Astrazeneca AB |
6,7,8,9-tetrahydro-3h-pyrazolo[4,3-f]isoquinoline derivatives useful in the treatment of cancer
|
|
ES2941631T3
(es)
|
2016-12-16 |
2023-05-24 |
Lilly Co Eli |
Compuestos de Pirido[4,3-d][1,3]oxazin-2-ona como inhibidores de IDH1 e IDH2 mutantes
|
|
KR102314286B1
(ko)
|
2016-12-16 |
2021-10-21 |
화이자 인코포레이티드 |
Glp-1 수용체 작용제 및 이의 용도
|
|
JP7291077B2
(ja)
|
2016-12-16 |
2023-06-14 |
ヤンセン ファーマシューティカ エヌ．ベー． |
Ｊａｋファミリーのキナーゼの低分子阻害物質
|
|
EP3555050A1
(en)
|
2016-12-16 |
2019-10-23 |
Basf Se |
Pesticidal compounds
|
|
TWI831738B
(zh)
|
2016-12-16 |
2024-02-11 |
美商瑞塔醫藥有限責任公司 |
用於抑制ＲＯＲγ及其他用途的嘧啶三環烯酮衍生物
|
|
JOP20190144A1
(ar)
|
2016-12-16 |
2019-06-16 |
Janssen Pharmaceutica Nv |
إيميدازو بيرولو بيريدين كمثبطات لعائلة jak الخاصة بإنزيمات الكيناز
|
|
GEP20207202B
(en)
|
2017-01-30 |
2020-12-25 |
Chiesi Farm Spa |
Tyrosine amide derivatives as rho-kinase inhibitors
|